industry pharmaceuticals biotech founded 1997 founder jean paul clozel martine clozel walter fischli andr j. m ller and thomas widmann headquarters gewerbestrasse 16 allschwil basel country switzerland area served research and development of medicines for unmet medical need key people jean paul clozel chief executive office guy braunstein global clinical development otto schwarz chief operating officer nicholas franco chief business officer andr c. muller chief financial officer products tracleer ventavis zavesca veletri opsumit revenue 1 929 mio chf operating income 457.3 mio chf net income 390.6 mio chf number of employees 2467 january 2011 website www.actelion.com actelion is a pharmaceuticals and bio technology company established in december 1997 headquartered in allschwil near basel in switzerland . 2 its ceo and co founder is cardiologist jean paul clozel . 3 actelion specializes in orphan diseases . 4 actelion scientists were among the first to work in the field of endothelian receptor antagonists . 5 the company name might be a reminder for its first product an endothelian receptor antagonist and the verb action act upon . actelion was initially financed with venture capital provided through a syndicate including atlas venture sofinnova and healthcap . actelion has 29 operative affiliates around the world including the united states canada brazil australia japan switzerland and a number of eu countries . the swiss affiliate is located in baden the german affiliate in freiburg the austrian one in vienna the french one in paris and the uk affiliate is located in london 6 in 2006 the company established the actelion endothelin research award programme which supports selected clinical research projects . contents 1 medicines 2 key figures 3 awards 4 notes and references 5 see also 6 external links medicines edit actelion currently has 10 compounds in its pipeline including 3 in late stage development and 4 medicines on the market for orphan diseases tracleer bosentan tracleer was the first oral treatment approved for pulmonary arterial hypertension a rare chronic life threatening disorder that severely compromises the functions of the lungs and heart . it is a dual endothelin receptor antagonist see also endothelin receptor antagonist . 7 zavesca miglustat is currently the only approved oral treatment for patients with mild to moderate type 1 gaucher disease for whom enzyme replacement therapy is unsuitable . type 1 gaucher disease is a rare and debilitating metabolic disorder . 8 ventavis iloprost ventavis is indicated for the treatment of pulmonary arterial hypertension who group 1 in patients with nyha class iii or iv symptoms . 9 veletri epoprostenol for injection is approved by the u.s. food and drug administration fda for the long term intravenous treatment of primary pulmonary hypertension and pulmonary hypertension associated with the scleroderma spectrum of disease in nyha class iii and class iv patients who do not respond adequately to conventional therapy . 10 key figures edit by january 2011 actelion had a total of 2 467 employees 392 in research 640 in development and 1017 in sales and marketing . in 2010 actelion s sales amounted to 1 929 million chf . 11 actelion s shares have been listed on the six swiss exchange ticker symbol atln since 2000 swx swiss exchange swiss leader index . in september 2008 actelion shares began trading as part of the swiss market index . 2 12 13 14 awards edit actelion received the prix herm s de l innovation herm s award for innovation in april 2011 15 the european institute for creative strategy and innovation the creator of the prix herm s was founded in 2003 in france . the performance report for swiss pharma websites awarded actelion the first prize in the second consecutive year . 16 notes and references edit http www.actelion.com en our company news and events index.page newsid 1489892 . missing or empty title help a b financial times . nature . medicine . businessweek . actelion affiliates . european medicines agency . european medicines agency . european medicines agency . news medical . actelion company homepage . swiss market index . ubs . the pharmaletter . prix herm s . prize for website pdf . see also edit list of pharmaceutical companies pharmaceutical industry in switzerland external links edit wikimedia commons has media related to actelion . official website official aera website permanent dead link v t e swiss market index companies of switzerland abb actelion adecco credit suisse geberit givaudan holcim julius b r nestl novartis richemont roche sgs swatch group swiss re swiss life swisscom syngenta ubs zurich financial companies portal switzerland portal retrieved from https en.wikipedia.org w index.php title actelion & oldid 742418547 categories pharmaceutical companies of switzerlandpharmaceutical companies established in 1997orphan drug companieslife sciences industryswiss brandshidden categories pages with citations lacking titlespages with citations having bare urlsuse dmy dates from april 2015pages using infobox company with unsupported parameterscommons category with local link same as on wikidataall articles with dead external linksarticles with dead external links from october 2016articles with permanently dead external links navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page print export create a bookdownload as pdfprintable version in other projects wikimedia commons languages deutsch fran ais portugu s edit links this page was last modified on 3 october 2016 at 16 02 . text is available under the creative commons attribution sharealike license ; additional terms may apply . by using this site you agree to the terms of use and privacy policy . wikipedia is a registered trademark of the wikimedia foundation inc. a non profit organization . privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view